Updates and News

MILWAUKEE and SALT LAKE CITY (August 21) — Today, Blackrock NeuroMed LLC and the Children’s Hospital of Wisconsin announced a clinical affiliation that will advance the treatment of childhood epilepsy and provide insight into other neurodegenerative diseases.

At the heart of the clinical affiliation is Blackrock NeuroMed’s Cervello System, which allows doctors to examine patients’ electrical brain activity at previously impossible levels of accuracy.

“Cervello dramatically improves our ability to treat epilepsy patients,” said Dr. Kurt Hecox, a pediatric neurologist at Children’s. “The system gives us a much clearer look at the electrical signals in patients’ brains. As a result, we can identify the precise region in the brain where a patient’s seizures are originating — and have it removed quickly and accurately.”

The Cervello System incorporates three primary technologies: an electroencephalogram, a high-definition video camera, and a sophisticated data-recording device that can monitor the brain’s electrical activity.

Children’s 25 Cervello units are housed in their pediatric epilepsy center, the highest-ranked such center in Wisconsin. Cervello is empowering researchers at Children’s to examine brain activity at the level of an individual neuron. That represents a significant improvement over the imprecise hundred- and thousand-neuron views offered by other EEG technology.

For the more than 300,000 American children with epilepsy, the treatment Cervello enables could be revolutionary.”Cervello is the new gold standard for EEG technology,” said Andy Gotshalk, CEO of Blackrock NeuroMed. “The system fuels cutting-edge epilepsy treatments that would have seemed like science fiction just a few years ago.”We hope that Cervello will empower researchers to better understand neurodegenerative disorders like depression, Alzheimer’s, and Parkinson’s — and eventually, to treat or even cure them.”

For additional info: http://www.chw.org/medical-care/neuroscience/inpatient-unit/


Blackrock NeuroMed will demonstrate its portfolio of revolutionary Cervello EEG / LTM technology during the annual American Academy of Neurology (AAN) Meeting held in Washington DC from April 20-23, 2015.

“Central to our company’s mission is unraveling the mystery of what causes different neurological disorders,” said Andrew Gotshalk, CEO Blackrock NeuroMed. “We look forward to attending this year’s AAN Conference so our team can demonstrate the potential of this highly-advanced technology that we believe will revolutionize diagnosis and therapy of epilepsy.”

The Cervello EEG/LTM Systems combines a full range of research and clinical capabilities.  The Cervello Systems are ideally suited for LTM in Epilepsy, Invasive and Stereo-EEG recording. System features include up to 256 channels, marco- and micro-electrode recording, high sampling rates, remote monitoring capabilities, Bluetooth wireless connectivity and full HD video recording.

Tom Keener, VP of Sales and Heidi Schultz, Regional Sales Manager will be at the NeuroMed Booth #1617 providing real-time demonstrations April 20-23.

In an interview with Blackrock NeuroMed’s CEO, Andrew Gotshalk, Medical Design Technology highlights the Cervello EEG technology.



Blackrock NeuroMed is pleased to support the 68th Annual meeting of the American Epilepsy Society (AES), December 5-8, in Seattle, Washington.

Along with a new exhibition booth highlighting the complete  product line, Blackrock NeuroMed is pleased to announce the addition of new team members due to continued company growth.  The newest team member is a local field-support representative in the Seattle area to support a NeuroMed installation at one of the largest hospital groups in the greater Seattle, Washington area.

Furthermore, we will have news to share with all of our visitors about the past year’s success in growing our installation base around the United States.   Please stop by to see us during the AES Annual Conference at Booth 817, Washington State Convention Center.